Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
about
FastProject: a tool for low-dimensional analysis of single-cell RNA-Seq dataCombination Treatment with PPARγ Ligand and Its Specific Inhibitor GW9662 Downregulates BIS and 14-3-3 Gamma, Inhibiting Stem-Like Properties in Glioblastoma Cells.Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenograftsPPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Metabolic Reprogramming in Glioma.miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?The transcription factor PPARα is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma.Targeting glioblastoma stem cells (GSCs) with peroxisome proliferator-activated receptor gamma (PPARγ) ligands.The effect of hydroxy safflower yellow A on coronary heart disease through Bcl-2/Bax and PPAR-γ.Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
P2860
Q31123178-C4D94713-325C-4536-983A-485D38DA452EQ33794951-A0DBE2D8-F064-401B-A50B-9E8EFB627C88Q35624661-8BA24442-1411-4C22-B931-69E26CC7112EQ37656960-761FA7A4-E08F-4E65-A0F9-514BCA3A0013Q39297355-2375098F-C7B1-4B20-9C6B-F5C2C7C17969Q42030001-8DBC0B71-153F-47F5-B222-994C22F666A6Q42737831-8782BEDD-B113-422B-A038-69F65C298F70Q48403304-3A38CDD9-6A09-4B9D-BA76-9C1093EF1495Q48946085-18E8F04D-25BA-4F4D-A267-3309FC86C47AQ49278092-A7D63A92-5742-4DC0-A35B-1C02E6A3495DQ50212482-A78BCBF3-10C7-4F99-9B8A-2ED9970E030F
P2860
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
@en
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma.
@nl
type
label
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
@en
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma.
@nl
prefLabel
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
@en
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma.
@nl
P2860
P356
P1476
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
@en
P2093
Hayley Patricia Ellis
Kathreena Mary Kurian
P2860
P356
10.3389/FONC.2014.00052
P577
2014-03-14T00:00:00Z